- Home
- Companies
- Mediprint Ophthalmics
- Products
- Mediprint - Contact Lens Drug Delivery ...
Mediprint - Contact Lens Drug Delivery Platform
We have proprietary printing technology and ink that allows for the sustained, continuous release of ophthalmic drugs via contact lenses and it is called the MediPrint process. Our unique process results in a novel way to for treat various eye diseases and conditions with a non-invasive, cost-effective treatment. We have an extensive global patent portfolio, comprising intellectual property around the world and covering glaucoma, dry eye, myopia, etc.
MediPrint™ lenses are the convenient, efficient and comfortable way to deliver ocular medications to the eye non-invasively.
Eye Care Patients
- No daily drops
- Continuous therapy
Eye Care Payers
- Cost neutrality
- More satisfied members and providers
Eye Care Professionals
- Higher patient satisfaction
- Greater income potential
Current Treatments’ Shortcomings
While eye drops have been around for over 40 years and remain the standard of care for over 90% of patients, they are plagued by only around a 50% compliance rate, by low bioavailability and by side effects.
This leads millions to continue to suffer, including from disease progression, and even thousands to experience preventable blindness.
There are vast unmet needs for better non-invasive and cost-effective treatment options in numerous multi-billion dollar markets.
Proprietary MediPrint™ Process
Unique contact lens drug delivery platform for effectively treating ocular diseases.
